# Recent changes in clinical trials across the globe



## Introduction
With reference to WHOâ€™s ICTRP dataset for the last 2 years and performed 2 times in the time range of two weeks.

## Top 10 Trial Conditions for 2 years


**Analysis Performed on 1st Feb, 2022**
![Analysis Performed on 1st Feb, 2022](https://github.com/balakrishnabadveli/knowledge_graphs/blob/main/Reports/Images/2022/Feb/Top%2010%20Trial%20Conditions%20Pie%20Chart%20Since%202%20Years_20220201_161350.png)

**Analysis Performed on 25th Jan, 2022**
![Analysis Performed on 25th Feb, 2022](https://github.com/balakrishnabadveli/knowledge_graphs/blob/main/Reports/Images/2022/Feb/Top%2010%20Trial%20Conditions%20Pie%20Chart%20Since%202%20Years_20220201_161352.png)


By seeing above two charts of analysis which were performed on 1st Feb 2022 and 25th Jan 2022 , we can observe that the changes of percentages of some trials in two weeks approximately.


| S. No. |             Trial Condition            | % Of first analysis | % Of second analysis |       Remarks      |
|:------:|:--------------------------------------:|:-------------------:|:--------------------:|:------------------:|
| 1      | Covid -19                              | 30.4                | 30                 | Increased by 0.3%  |
| 2      | Pain Diabetes Mellitus                      | 8.2                 | 8.16                 | Decreased by 0.04% |
| 3      | Healthy Volunteers                     | 7.54                | 7.50                 | Decreased by 0.04% |
| 4      | Breast Cancer                          | 4.79                | 4.77                 | Decreased by 0.02% |
| 5      | Knee Osteoarthritis                    | 4.65                | 4.61                 | Decreased by 0.04% |
| 6      | Mental Issues                          | 4.1                 | 4.09                 | Decreased by 0.01% |
| 7      | Chronic Obstructive Pulmonary Diseases | 4.04                | 4.04                 | No Change          |
| 8      |                                    | 3.87                | 3.84                 | Decreased by 0.03% |
| 9      | O- Medical and Surgical                | 3.65                | 3.68                 | Increased by 0.03% |


From the above there is a 0.3% increment  in Covid-19 and 0.03% increment  in O- Medical and Surgical.


## Distribution of Source Register across Study types for 2 years

**Analysis performed on 1st Feb, 2022**
![Sankey-1 : Source to Study type](https://github.com/balakrishnabadveli/knowledge_graphs/blob/main/Reports/Images/2022/Feb/Top%2010%20Trial%20Conditions%20Pie%20Chart%20Since%202%20Years_20220201_161350.png)


**Analysis performed on 25th Jan, 2022**
![Sankey-1 : Source to Study type](https://github.com/balakrishnabadveli/knowledge_graphs/blob/main/Reports/Images/2022/Feb/Top%2010%20Trial%20Conditions%20Pie%20Chart%20Since%202%20Years_20220201_161350.png)


| S.NO | Source Register | Interventional | Observations | Others |
|:----:|:---------------:|:--------------:|:------------:|:------:|
|      |                 |                |              |        |
|   1  |      ACTRN      |      -186      |      -35     |        |
|   2  |       CRIS      |       -63      |      -32     |        |
|   3  |       CTRI      |       -23      |      -9      |    0   |
|   4  |      ChiCTR     |       -36      |      -13     |   -2   |
|   5  |       DRKS      |       -73      |      -70     |        |
|   6  |      EUCTR      |       -79      |              |        |
|   7  |       IRCT      |      -346      |       0      |        |
|   8  |      ISRCTN     |      --127     |      -38     |   -1   |
|   9  |       JPRN      |       -98      |      -19     |   -1   |
|  10  |      LBCTR      |       -2       |       0      |        |
|  11  |       NCT       |      -1370     |     -529     |   -11  |
|  12  |       NTR       |       -9       |      -10     |    0   |
|  13  |      PACTR      |       -15      |              |        |
|  14  |      REBEC      |       -19      |      -56     |        |
|  15  |      REPEC      |        0       |      -1      |        |
|  16  |      RPCEC      |       -5       |              |        |
|  17  |      SLCTR      |       -5       |              |        |
|  18  |       TCTR      |       -63      |      -44     |        |


# Distribution of Source Register across Trial Conditions for 2 years

| S.No | Source Register | Breast Cancer | COPD | Covid-19 | Diabetes | Healthy Volunteers  | Knee Osteoarthriti | Mental Issues | Pain | Stroke | Medical and Surgical |
|:----:|:---------------:|:-------------:|:----:|:--------:|:--------:|:-------------------:|:------------------:|:-------------:|:----:|:------:|:--------------------:|
|   1  |      ACTRN      | 0             | 0    | 0        | 0        | 1                   | 2                  | 0             | 0    | 0      |                      |
|   2  |       CRIS      |               |      |          |          |                     |                    |               |      |        |                      |
|   3  |       CTRI      | 1             | 1    | 0        | 5        | 0                   | 1                  | 0             | 0    | 0      | 1                    |
|   4  |      ChiCTR     | 3             | 15   | 0        | 4        | 0                   | 6                  | 2             | 2    | 4      |                      |
|   5  |       DRKS      | 0             | 1    | 0        | 0        | 1                   | 0                  | 1             | 1    | 0      |                      |
|   6  |      EUCTR      | 0             | 1    | 0        | 1        | 0                   | 1                  | 0             | 0    | 0      |                      |
|   7  |       IRCT      | 0             | 1    | 0        | 1        | 0                   | 2                  | 2             | 3    | 0      |                      |
|   8  |      ISRCTN     |               |      |          | 1        | 1                   |                    | 1             | 1    |        |                      |
|   9  |       JPRN      | 2             | 0    | 0        | 3        | 8                   | 1                  | 0             | 2    | 2      |                      |
|  10  |      LBCTR      | 0             |      | 0        |          | 0                   |                    | 0             |      |        |                      |
|  11  |       NCT       | 7             | 5    | 0        | 16       | 14                  | 9                  | 9             | 11   | 9      |                      |
|  12  |       NTR       | 0             | 0    | 0        | 0        | 1                   | 0                  | 0             | 0    | 0      |                      |
|  13  |      PACTR      |               |      | 0        | 0        | 0                   |                    |               |      |        |                      |
| 14   |      REBEC      | 0             | 0    | 0        | 0        | 0                   | 0                  | 0             | 0    | 1      |                      |
| 15   |      REPEC      |               |      |          |          |                     |                    |               |      |        |                      |
| 16   |      RPCEC      |               |      | 0        | 0        |                     |                    |               |      | 0      |                      |
| 17   |      SLCTR      |               |      | 0        | 0        |                     |                    | 0             |      | 0      |                      |
| 18   |       TCTR      | 0             | 0    | 0        | 0        | 2                   | 0                  | 0             | 0    | 0      |                      |
|  18  |       TCTR      |      -63      |  -44 |          |          |                     |                    |               |      |        |                      |


The above table represents the increment in clinical trials registrations in two weeks approximately.
From the above table, clinical trials on Covid-19 were registered from almost every Source. Diabetes Mellitus , Psychological problems and Stroke are also health issues in almost every nation. 

# Flow of Trials across Sources to Study types to Conditions for 2 years
